p-(diethylaminomethyl)benzonitrile | 69293-74-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: p-(diethylaminomethyl)benzonitrile
• 英文别名: N,N-diethyl(4-cyanobenzyl)amine；diethyl(4-cyanophenylmethyl)amine；4-diethylaminomethyl-benzonitrile；4-Diaethylaminomethyl-benzonitril；4-[(Diethylamino)methyl]benzonitrile；4-(diethylaminomethyl)benzonitrile
• CAS: 69293-74-9
• 化学式: C₁₂H₁₆N₂
• mdl: MFCD09948026
• 分子量: 188.272
• InChiKey: XWLYXADFVFHUKA-UHFFFAOYSA-N

物化性质

• 沸点：
  155-160 °C(Press: 20 Torr)
• 密度：
  0.99±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  27
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2926909090
• 危险性防范说明：
  P264,P280,P302+P352,P305+P351+P338,P332+P313,P337+P313,P362
• 危险性描述：
  H315,H319
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-[(Diethylamino)methyl]benzonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-[(Diethylamino)methyl]benzonitrile
CAS number: 69293-74-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H16N2
Molecular weight: 188.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  p-(diethylaminomethyl)benzonitrile 在 盐酸 作用下， 生成 4-乙氨基甲基苯甲酸
  参考文献：
  名称：

  Alkamine derivatives of para aminomethyl benzoic acid

  摘要：

  公开号：

  US02406627A1
• 作为产物：
  描述：

  二乙胺 、 对氰基溴化苄 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 反应 8.0h， 生成 p-(diethylaminomethyl)benzonitrile
  参考文献：
  名称：

  N-苄基苯甲酰胺衍生物作为选择性亚纳摩尔丁酰胆碱酯酶抑制剂用于晚期阿尔茨海默病的可能治疗

  摘要：

  在此，我们报告了一系列针对丁酰胆碱酯酶 (BChE) 的选择性亚纳摩尔抑制剂。这些带有新型N-苄基苯甲酰胺支架的化合物可抑制 BChE，IC 50从皮摩尔到纳摩尔。表面等离子共振测定证实了抑制活性，显示出亚纳摩尔K D值，这表明化合物通过直接与BChE结合发挥抑制作用。几种化合物显示出通过氧化损伤模型验证的神经保护作用。此外，体内急性毒性试验证明了S11-1014和S11-1033的安全性。在行为研究中，0.5 mg/kg S11-1014或S11-1033对 Aβ 1-42诱导的认知障碍表现出显着的治疗效果，几乎等同于 1 mg/kg 卡巴拉汀的治疗。药代动力学研究表征了S11-1014的代谢稳定性。因此，N-苄基苯甲酰胺抑制剂是一种很有前途的化合物，具有改善认知功能障碍的药物样特性，为治疗阿尔茨海默病提供了潜在的策略。

  DOI：

  10.1021/acs.jmedchem.2c00944

文献信息

• [EN] PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE SOUS FORME DE PYRAZOLOPYRIMIDINES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2004009602A1

  公开（公告）日：2004-01-29

  The present invention relates generally to inhibitors of the kinases and more particularly to novel pyrazolopyrimidine compounds.

  本发明一般涉及激酶的抑制剂，更具体地涉及新型吡唑吡嘧啶化合物。
• Lewis Acid-Catalyzed Reductive Amination of Carbonyl Compounds with Aminohydrosilanes
  作者：Katsukiyo Miura、Kazunori Ootsuka、Shuntaro Suda、Hisashi Nishikori、Akira Hosomi

  DOI：10.1055/s-2001-17486

  日期：——

  The TiCl4-catalyzed reaction of aromatic carbonyl compounds with (dialkylamino)dimethylsilanes gave tertiary amines in moderate to high yields. The reductive amination of aliphatic aldehydes was effectively catalyzed by ZnI2. Methyl N-(dimethylsilyl)carbamate as well could be used for reductive amination of carbonyl compounds in the presence of Ph3CClO4.

  四氯化钛催化的芳香醛与(二烷基氨基)二甲基硅烷反应，能以中等至高产率得到叔胺。脂肪醛的还原胺化反应也受到ZnI2的有效催化。在存在Ph3CClO4的情况下，甲基N-(二甲基硅基)氨基甲酸酯同样可用于羰基化合物的还原胺化。
• Simple Metal-Free Direct Reductive Amination Using Hydrosilatrane to Form Secondary and Tertiary Amines
  作者：Sami E. Varjosaari、Vladislav Skrypai、Paolo Suating、Joseph J. M. Hurley、Ashley M. De Lio、Thomas M. Gilbert、Marc J. Adler

  DOI：10.1002/adsc.201700079

  日期：2017.6.6

  This work describes the use of cheap, safe, and easy-to-handle hydrosilatrane as the reductant in direct reductive amination reactions. This efficient method enables a facile, metal-free access to secondary and tertiary amines from a wide range of aldehydes and ketones, with the synthesis of tertiary amines requiring no additives at all. This reaction demonstrates excellent functional group tolerance

  这项工作描述了在直接还原胺化反应中使用便宜，安全且易于操作的氢化硅环烷作为还原剂。这种高效的方法可以轻松，无金属地从各种醛和酮中获得仲胺和叔胺，而叔胺的合成则完全不需要添加剂。该反应显示出优异的官能团耐受性，化学选择性和可扩展性。
• Carboxamide compounds and their use as calpain inhibitors
  申请人：Kling Andreas

  公开号：US20080234330A1

  公开（公告）日：2008-09-25

  The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula I in which R 1 , R 2 , R 3a , R 3b , W, Y and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula I-A.a′ and I-A.a″ in which m, E, R 1 , R 3a , R 3b , R 2 , R y , R w and R w6 * have the meanings mentioned in the claims, n is 0, 1 or 2, the tautomers thereof and the pharmaceutically suitable salts thereof.

  本发明涉及新型羧酰胺化合物及其用于制备药物的用途。这些羧酰胺化合物是钙蛋白酶（依赖于钙的半胱氨酸蛋白酶）的抑制剂。因此，本发明还涉及利用这些羧酰胺化合物治疗与升高的钙蛋白酶活性相关的疾病。这些羧酰胺化合物是具有一般式I的化合物，其中R1、R2、R3a、R3b、W、Y和X具有所述权利要求书和说明中提到的含义，其互变异构体和药用盐。具体而言，这些化合物具有一般式I-A.a′和I-A.a″，其中m、E、R1、R3a、R3b、R2、Ry、Rw和Rw6*具有权利要求书中提到的含义，n为0、1或2，其互变异构体和药用盐。
• <i>tert</i> -Butoxy-Radical-Promoted α-Arylation of Alkylamines with Aryl Halides
  作者：Ryota Ueno、Yuko Ikeda、Eiji Shirakawa

  DOI：10.1002/ejoc.201700548

  日期：2017.8.2

  In the presence of a tert-butoxy radical precursor, the reaction of alkylamines with aryl halides was found to give alpha-arylated alkylamines through homolytic aromatic substitution of the halogen atoms.

  在叔丁氧基自由基前体的存在下，发现烷基胺与芳基卤化物的反应通过卤素原子的均裂芳族取代得到α-芳基化烷基胺。